All Stories
Follow
Subscribe to DocCheck AG

DocCheck AG

euro adhoc: DocCheck AG
Buybacks
DocCheck AG continues its share buy-back programme

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
05.06.2007
Cologne, 5 June 2007 - DocCheck AG (ISIN DE0005471007 //Symbol 
547100) has today completed the second phase of its share buy-back 
programme and now holds 191,500 of its own shares, which equates to 
3.2 per cent of the capital stock. The DocCheck AG Board of Directors
decided to continue the buy-back programme and to purchase a further 
100,000 shares. The basis for the share buy-back is the resolution 
adopted at the Annual General Meeting held on 31 May 2006 which 
empowered the company to buy back a maximum of 590,431 shares by 30 
November 2007 (10 per cent of the capital stock). The purchase of the
shares starts on 6 June 2007 and takes place exclusively via the 
stock exchange. The purchase price paid per share must not fall below
or exceed by more than 10 per cent the price of a company share as 
determined by the opening auction held on the same trading day on the
XETRA trading platform. The aim of the share buy-back is to optimise 
the capital structure. All transactions carried out during the course
of the share buy-back programme are published weekly on the DocCheck 
AG website (www.doccheck.ag) under the heading Investor/Share 
Buy-Back.
end of announcement                               euro adhoc 05.06.2007 20:00:00

Further inquiry note:

Tanja Mumme
+49 (0)221 92053 139
tanja.mumme@doccheck.com

Branche: Computing & Information Technology
ISIN: DE0005471007
WKN: 547100
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime
standard
Börse Berlin-Bremen / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade

Original content of: DocCheck AG, transmitted by news aktuell

More stories: DocCheck AG
More stories: DocCheck AG